Literature DB >> 15190195

Hepatocyte transplantation for inborn errors of metabolism.

A B Burlina1.   

Abstract

Liver transplantation for inborn errors of metabolism has proved effective in some (mostly liver-associated) inborn errors of metabolism. Significant morbidity and mortality rates have been extensively reported due to disease recurrence or to complications of the immunosuppressive regimen. On the basis of clinical trials in animals as well as in humans, the use of isolated hepatocytes offers a unique opportunity for treating inborn errors of metabolism. The state of art of the technique applied to this field is reviewed here and related practical problems are examined. No final conclusions can be drawn, but further insight into the use of alternative sources of cells, including stem/progenitor cells associated with cryobiology and immunological research, will offer new opportunities for cell therapy for inborn errors of metabolism in the near future.

Entities:  

Mesh:

Year:  2004        PMID: 15190195     DOI: 10.1023/B:BOLI.0000031095.57411.8d

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  48 in total

1.  Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.

Authors:  Maurizio Muraca; Giorgio Gerunda; Daniele Neri; Maria-Teresa Vilei; Anna Granato; Paolo Feltracco; Muzio Meroni; Gianpiero Giron; Alberto B Burlina
Journal:  Lancet       Date:  2002-01-26       Impact factor: 79.321

2.  Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats.

Authors:  Y Yoshida; Y Tokusashi; G H Lee; K Ogawa
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

3.  The antigenicity of purified liver parenchyma cells.

Authors:  L Brent; A G Bain; R Butler; T Horsburgh; S C Opara; P J Wood
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

4.  Loss of p27(Kip1) enhances the transplantation efficiency of hepatocytes transferred into diseased livers.

Authors:  A N Karnezis; M Dorokhov; M Grompe; L Zhu
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

5.  Long-term survival after liver transplantation in children with metabolic disorders.

Authors:  Liise K Kayler; Robert M Merion; Samuel Lee; Randall S Sung; Jeffrey D Punch; Steven M Rudich; Jeremiah G Turcotte; Darrell A Campbell; Ronald Holmes; John C Magee
Journal:  Pediatr Transplant       Date:  2002-08

6.  Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up.

Authors:  Etienne M Sokal; Françoise Smets; Annick Bourgois; Lionel Van Maldergem; Jean-Paul Buts; Raymond Reding; Jean Bernard Otte; Veerle Evrard; Dominique Latinne; Marie Françoise Vincent; Anne Moser; Humberto E Soriano
Journal:  Transplantation       Date:  2003-08-27       Impact factor: 4.939

7.  Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.

Authors:  K Overturf; M Al-Dhalimy; R Tanguay; M Brantly; C N Ou; M Finegold; M Grompe
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

Review 8.  Hepatic regeneration from hematopoietic stem cells.

Authors:  Timothy W Austin; Eric Lagasse
Journal:  Mech Dev       Date:  2003-01       Impact factor: 1.882

9.  Human hepatocyte isolation and relationship of cell viability to early graft function.

Authors:  Ragai R Mitry; Robin D Hughes; Marion M Aw; Claire Terry; Giorgina Mieli-Vergani; Raffaele Girlanda; Paolo Muiesan; Mohamed Rela; Nigel D Heaton; Anil Dhawan
Journal:  Cell Transplant       Date:  2003       Impact factor: 4.064

10.  A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia.

Authors:  M Grossman; D J Rader; D W Muller; D M Kolansky; K Kozarsky; B J Clark; E A Stein; P J Lupien; H B Brewer; S E Raper
Journal:  Nat Med       Date:  1995-11       Impact factor: 53.440

View more
  7 in total

Review 1.  Embryonic and induced pluripotent stem cells as a model for liver disease.

Authors:  Hiroshi Yagi; Edgar Tafaleng; Masaki Nagaya; Marc C Hansel; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Crit Rev Biomed Eng       Date:  2009

2.  Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates.

Authors:  Olivier Menzel; Jacques Birraux; Barbara E Wildhaber; Caty Jond; Françoise Lasne; Walid Habre; Didier Trono; Tuan H Nguyen; Christophe Chardot
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

3.  Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells.

Authors:  Karim Si-Tayeb; Fallon K Noto; Masato Nagaoka; Jixuan Li; Michele A Battle; Christine Duris; Paula E North; Stephen Dalton; Stephen A Duncan
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

Review 4.  Therapeutic liver repopulation for phenylketonuria.

Authors:  Cary O Harding; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2010-05-22       Impact factor: 4.982

Review 5.  Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects.

Authors:  Kara R Vogel; Andrew A Kennedy; Luke A Whitehouse; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2013-10-02       Impact factor: 4.982

Review 6.  Liver cell transplantation for the treatment of inborn errors of metabolism.

Authors:  J Meyburg; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

7.  Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress.

Authors:  Huey-Ling Chen; Hui-Ling Chen; Ray-Hwang Yuan; Shang-Hsin Wu; Ya-Hui Chen; Chin-Sung Chien; Shi-Ping Chou; Renxue Wang; Victor Ling; Mei-Hwei Chang
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.